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Highlights: 
• Electrical microstimulation to modulate neural activity has emerged as a critical tool in brain
research, neurotherapeutics, and bidirectional neuroprostheses.
• Recent successes in sensory, motor, auditory, visual, and cognitive neuroprostheses
demonstrate a need for more focal micro-neuromodulation technologies.
• Advances in electronics, optics, and magnetics are leading towards stable, high spatial-
resolution interfaces.
• Advances in neuroprosthetic technologies may one day enable single neuron, whole-brain
micro-neuromodulation.
Abstract: 
Electrical stimulation technologies capable of modulating neural activity are well established for 
neuroscientific research and neurotherapeutics. Recent micro-neuromodulation experimental results 
continue to explain neural processing complexity and suggest the potential for assistive technologies 
capable of restoring or repairing of basic function. Nonetheless, performance is dependent upon the 
specificity of the stimulation. Increasingly specific stimulation is hypothesized to be achieved by 
progressively smaller interfaces. Miniaturization is a current focus of neural implants due to 
improvements in mitigation of the body’s foreign body response. It is likely that these exciting 
technologies will offer the promise to provide large-scale micro-neuromodulation in the future. Here, 
we highlight recent successes of assistive technologies through bidirectional neuroprostheses currently 
being used to repair or restore basic brain functionality. Furthermore, we introduce recent 
neuromodulation technologies that might improve the effectiveness of these neuroprosthetic interfaces 
by increasing their chronic stability and microstimulation specificity. We suggest a vision where the 
natural progression of innovative technologies and scientific knowledge enables the ability to selectively 
micro-neuromodulate every neuron in the brain. 
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Introduction  
The fields of neuroscience, medicine, and neural engineering have made great strides in how we 
interface the central nervous system to study normal function and treat injuries and diseases. The NIH 
Sponsored B.R.A.I.N. initiative aims to develop innovative technologies for studying individual cells and 
complex neural circuits [1,2]. These technologies aim for cellular and sub-cellular resolution, setting 
ambitious goals that include recording from every neuron in a single brain simultaneously. However, in 
addition to recording, the activation of these individual cells offers the promise of propelling forward 
both basic science and medicine. We envision technologies that will enable independent modulation of 
every neuron in a single brain, i.e., “whole-brain micro-neuromodulation.” In this review, we will first 
highlight advances in science and engineering that are developing higher resolution stimulation 
approaches to enhance performance and translation of recent neuroprosthetic successes. Subsequently, 
we will detail several promising new technologies that may enable even larger-scale and cellular-
resolution micro-neuromodulation in the near future. 
Current neuromodulation offers various clinical approaches that provide powerful alternatives to 
patients otherwise refractory to available treatments. Clinical neuromodulation therapies, such as deep 
brain stimulation (DBS), have been widely used for the treatment of Parkinson’s disease [3–5] and 
essential tremor [6]. DBS has also shown great potential for the treatment of a variety of neurological 
disorders, including, obsessive-compulsive disorder [7], Tourette’s syndrome [8,9], Alzheimer’s disease 
[10,11], alcoholism [12], and depression [13]. Similarly, less invasive approaches such as transcranial 
magnetic stimulation (TMS) has demonstrated neurorehabilitation potential [14], as well as, 
effectiveness in the treatment of depression [15,16], and neuropathic pain [17,18]. However, both DBS 
and TMS performance are limited by their poor spatial resolution: namely, the inability to focally 
microstimulate specific neurons or neuronal clusters [19]. For instance, DBS macroelectrodes are 
estimated to excite approximately 500,000 neurons simultaneously [20]. This low specificity is likely a 
source off-target stimulation [21–23] which has been attributed as a source of neuropsychological post-
stimulation side effects [24], such as increased impulsivity [25,26] and verbal fluency decline [27,28]. 
Even though the precise effects of stimulation on the activity of neuronal populations remains 
controversial (see [29–31] for a discussion of clustered vs. distributed population activation by 
microstimulation), it can be assumed that advances in interfacing technologies will gradually allow for 
more selective microstimulation. Regardless of whether microstimulation activates clusters of neurons 
local to the implanted device, or sparse, widespread populations, it is likely that advanced technologies 
will allow more selective activation of specific neuronal populations. This focal microstimulation, 
providing high-resolution activation of small neuronal populations, will offer unparalleled advantages in 
neuromodulation [32]. These advantages, including more selective activation of the intended target, 
may result in both fewer off-target effects in neuromodulation therapeutics [21,22,27], as well as 
futuristic assistive technologies for sensory, motor, and cognitive repair [11,33–35].  
Existing microstimulation technologies, such as intracortical microelectrodes, must overcome critical 
challenges in order to achieve chronically stable whole-brain micro-neuromodulation. One of these 
challenges is the design of high-resolution interfaces through advanced materials and state-of-the-art 
microfabrication techniques (see [36]). Another challenge is the development of chronically stable 
devices capable of withstanding abiotic factors related to device breakdown [37] and biotic failures 
associated the foreign body response (FBR). The FBR is characterized by neuronal death, tissue 
encapsulation, and reduced functional longevity [37–40]. Multidisciplinary efforts for advanced device 
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manufacturing for greater abiotic stability [41–43] as well as mitigation of the FBR [44–59] are 
concurrently being investigated. 
 
The requirements from the latest breakthroughs in microstimulation-based neuroprostheses, as well as 
state-of-the-art advances in neuromodulation technologies, suggest that the field is naturally 
progressing towards multichannel micro-neuromodulation. These technologies are shifting the 
stimulation spatial resolution scale from the network level to the cellular (and sub-cellular) level. The 
perceived quality and adaptability of future prosthetics will be bolstered by advances in neuroscience, 
the consolidation of functional maps with neuronal resolution, and the ability to selectively modulate 
those neurons. For the remainder of this review, we will discuss current successes in sensory, motor, 
and cognitive prostheses. We will then highlight novel technologies that are overcoming drawbacks that 
may one day enable whole brain micro-neuromodulation. 
 
Figure 1. 
Overview of stimulation spatial resolution and its effects on somatosensory and visual neuroprostheses. (A) Low 
spatial resolution stimulation inducing blunt visual and sensory percepts. (B) High spatial resolution 
neuromodulation showing discrete activation of neuronal clusters. This increase in stimulation specificity will likely 
allow for higher quality, more naturalistic neuroprostheses.  
Recent Microstimulation Success 
Advances in brain-machine interfaces (BMI) have resulted in continually improving assistive technologies 
to increase the quality of life of patients with neurological deficits [60]. BMI’s progress has been possible 
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by innovations in computational algorithms, neuroscience knowledge, and predominantly, interfacing 
neuroprosthetic technologies (namely, the ability to record and/or microstimulate neuronal activity). 
Likewise, novel microstimulation technologies and targets may potentially propel forward advances and 
translational efforts in neuroprosthetics for patients with sensorimotor, visual, auditory, and cognitive 
deficits. In the following sections, we will briefly describe some of latest breakthroughs and assess 
critical challenges facing microstimulation neuroprostheses.  
 
Somatosensory Neuroprostheses 
Interfacing intracortical motor recordings [61,62] with complex decoding and prediction 
computer algorithms [63–65] has allowed tetraplegic patients to control robotic prosthetic limbs with 
several degrees of freedom [66–68]. Nevertheless, touch feedback is crucial for the proper biomimetic 
operational control of these interfaces [33]. Pioneering studies in non-human primates (NHP) by Romo 
et al. [69] demonstrated that microstimulation of somatosensory cortex (S1) could reproduce behaviors 
similar to the sense of touch [69–73]. Moreover, NHP somatosensory cortex microstimulation has led to 
further advances such as integrating sense of touch into a prosthetic hand [74] through bidirectional 
BMI [75,76] (For an extended review: see [33]). Less than two decades after Romo’s seminal 
breakthrough [69], penetrating microelectrodes [77] and electrocorticographic (ECoG) arrays [78,79] 
were implanted into somatosensory cortices of human volunteers to restore the sense of touch. The 
results of both of these studies demonstrated that, even with the status of neuromodulation 
technologies, somatosensory microstimulation is capable of eliciting naturalistic percepts of pressure, as 
well as, discrete spatial discrimination of touch. The detection thresholds, as well as the perceived 
quality of these percepts, depended on the stimulation parameters used [77,78]. Over time, 
spontaneous percepts were mitigated, and the patient was able to detect percepts from a higher 
number of electrodes. Similarly, the number of independent electrodes that the patient could 
discriminate gradually increased [77], suggesting an important role for neuroplasticity in the adaptation 
of these implants. Moreover, advances in sensory topographies [80], biomimetic feedback [81], and 
selective micro-neuromodulation have the potential to drive improvements in artificial somatosensation 
and spatial discrimination elicited by these devices (Fig. 1B- Top). 
 
Auditory Neuroprostheses 
The use of neuroprostheses to restore hearing is one of the oldest clinically available 
neuroprosthetic technologies. Worldwide, more 300,000, cochlear implants (CI) have allowed patients 
with auditory deficits to restore hearing and improve their quality of life [82]. Due to neurophysiological 
properties of the cochlea and the limited neural interface, CIs have many inherent drawbacks that 
compromise their performance. These include impaired pitch and music perception, speech 
comprehension in noisy backgrounds, and sound localization [35,83].   Approaches to overcome these 
challenges such as augmenting the number of effective electrodes and mitigating current spillover 
through focal stimulation have shown only modest results [35]. Alternative stimulation targets with 
direct neuronal interfacing may contribute to more naturalistic auditory neuroprostheses. For instance, 
interfacing directly with the auditory nerve offers several potential advantages over CI, including a 
broader frequency range, reduced interference, and lower activation thresholds [84].  
 
Other alternatives such as the auditory brainstem implants (ABI) [85] and auditory midbrain 
implants (AMI) [86] targeting the cochlear nucleus and inferior colliculus, respectively, have also been 
tested clinically. Although far less common and less effective than CI, ABI and AMI have been shown as a 
suitable approach to patients to whom CIs or auditory nerve implants are not feasible [87,88]. An 
additional potential target for auditory neuroprostheses is the medial geniculate nucleus of the 
thalamus. Animal studies have shown that thalamic stimulation might elicit ranges similar to CIs with 
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lower stimulation thresholds than AMI and ABI [89]. Lastly, primary auditory cortex microstimulation 
stands as a prospective target for auditory neuroprostheses. Otto et al. used a discrimination task to 
assess intracortical microstimulation of the auditory cortex of behaving rats. The results of these 
experiments indicated that the tonotopic location of the microelectrode correlates with the perceived 
frequency of the stimulus [90,91]. Moreover, microstimulation evoked faster responses than natural 
hearing [91]. Similar tonotopic activation has been reported in human electrical stimulation [92], and 
fMRI studies [93], suggesting potential translatability of these interfaces.  
 
The aforementioned experiments have identified promising auditory neuroprosthetic targets 
that might, one day, restore normal hearing of deaf patients. The emergence of massively parallel micro-
neuromodulation channels that can stimulate small neuronal populations independently will likely 
continue to add to the quality of auditory sensation, limiting the perceived frequency spread and 
enhancing the temporal resolution. 
 
Visual Neuroprostheses 
The potential of microstimulation to restore sight for the blind was established after the finding 
more than 80 years ago that stimulation of the visual cortex elicited localized phosphenes [94]. Since 
then, several potential visual neuroprosthetic targets along the visual pathway have been identified. 
Moreover, neural implants have shown substantial restoration of sight in low-vision patients. Retinal 
implants have shown great clinical and commercial success, enabling substantial improvements in 
motion detection, word recognition, and acuity tasks in blind patients [95,96] (See: [97] for an extended 
review). Despite these successes, due to anatomical constraints, retinal implants may never offer 
extreme high-resolution artificial vision. However, the visual cortex offers great potential for high-
resolution visual prostheses [98]. The feasibility of visual cortex implants was recognized by human trials 
[99–101]. These experiments led to important insights and considerations for future developments of 
visual cortex prostheses and neural implants in general, including the importance of spatial resolution 
and proper neuromodulation parameters. For instance, the charge necessary to reach threshold and 
evoke phosphenes of intracortical (penetrating) electrodes was orders of magnitude lower compared 
with cortical surface stimulation [101,102]. Likewise, high stimulation currents disrupted the color and 
quality of evoked phosphenes [101]. Furthermore, electrodes separated by at least 0.5 mm were able to 
elicit independent phosphenes. Currently, multidisciplinary efforts to develop a reliable visual cortex 
implants have been recently proposed [103–105] (see [106] for a review). Yet, several scientific and 
technological challenges must be overcome before the implementation of fully functional visual cortex 
prostheses. For instance, a detailed understanding of the encoding used within the primary visual and 
striate cortices can result in enriched receptive field mapping [107] and phosphene prediction models 
[108]. Combining these topographic models with specific spatiotemporal neuromodulation can 
potentially elicit real-time, high-quality percepts. Along the same lines, experiments in NHP suggest that 
microstimulation of visual association areas influences object perception, including direction [109] and 
faces [110]. Hence, coordinated neuromodulation of visual cortex with visual association areas could 
potentially alter the perception and connotation of elicited phosphenes. See [111] for an extended 
review.  Moreover, future prosthetic implementations must take into account the role of training and 
plasticity in chronic functional implants. Additionally, alternative stimulation targets, such as the optic 
nerve [112,113] and lateral geniculate nucleus (LGN) [114], have been studied for neuroprosthetic 
interfaces. Though still in development, advances in high-resolution brain mapping and micro-
neuromodulation will likely improve the visual resolution of the perceived images, as well as the spatial 
patterns observed during natural vision, in all of these visual prosthesis targets [101] (Fig. 1 - Bottom). 
 
Motor Neuroprostheses 
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Even though direct neuromodulation of motor cortex for locomotion has been challenging due 
to the lack of fine motor tuning [115] and its impracticality in spinal cord injury patients [116], it has 
been widely used for brain mapping [117,118] and functional neurorehabilitation [119,120]. Typically, 
motor cortex serves as the efferent component of bidirectional brain-machine interfaces. Recordings 
from primary motor cortex serve to direct neuromodulation of specific targets, including the spinal cord 
(via intraspinal microstimulation (ISMS) or epidural stimulation) and functional electrical stimulation for 
the periphery [121]. These approaches have recently allowed paralyzed NHPs to reach and grasp 
[122,123], and effectively restore leg locomotion [34]. Moreover, recent human trials have shown 
successful limb control in paralyzed patients [124,125]. Although, aside from ISMS, these stimulation 
techniques are not strictly classified as microstimulation, high spatiotemporal resolution 
neuromodulation has the potential to continue to improve the overall sustainability and naturalistic 
performance of these interfaces. Focal neuromodulation can substantially help overcome some of the 
challenges facing current motor prostheses. These include the need to drastically reduce muscle fatigue, 
electrical spillover, and high power consumption [126]. Moreover, micro-neuromodulation in 
combination with functional mapping would drastically enhance selective control of independent 
muscular bundles for fine motor control [127]. Finally, the chronic stability of both recording and 
stimulating interfaces (see Invasive Neuromodulation section) is necessary for closed-loop motor and 
touch integration in the translation of future, fully-functional clinical motor neuroprostheses [75]. 
Cognitive Neuroprostheses 
Restoration of cognitive abilities has emerged as an intriguing micro-neuromodulation target. 
Microstimulation of hippocampal cells demonstrated enhancements in memory performance tasks in 
rodents [128] and NHPs [129]. These microstimulation experiments were feasible by a nonlinear multi-
input multi-output (MIMO) model that allowed online extraction of the patterns of firing of hippocampal 
cells during memory tasks to provide effective pulses of microstimulation in real time [128]. Similarly, 
human studies have shown that neuromodulation via DBS of other potential targets such as the medial 
temporal lobe can significantly improve tasks of verbal recall [130] and spatial memory [11,131]. More 
recently, Ezzyat et al., demonstrated that these memory enhancements via neuromodulation are 
dependent on current brain encoding state [132], further supporting the importance of bidirectional 
(afferent and efferent) BMI [133]. These findings indicate that controlled neuromodulation of specific 
brain targets may be used in the future to treat patients with memory disorders and cognitive 
dysfunctions. As we expand our understanding of the circuitry involved in the acquisition, consolidation, 
and retrieval of memories, the efficacy of current cognitive prostheses can improve significantly by using 
micro-neuromodulation with high spatial and temporal precision.  Even though the implementation of 
these type of neuroprostheses might have unparalleled clinical applications, several ethical questions 
are important to discuss [134].  
 
Recent neuromodulation technologies 
Invasive Neuromodulation 
 Electrical 
The advancement of neuroscientific research and therapeutic performance of current 
neuroprostheses are dependent on the robustness, reliability, and predominantly the spatiotemporal 
resolution of the interfacing neuromodulation technology. Due to its long history of usage, safety 
profile, cortical depth selectivity, and low threshold currents [101,135], penetrating electrical 
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stimulation has been the gold standard for the vast majority of aforementioned neuroprosthetic 
successes [60](Figure 3A). Novel silicon microelectrodes [136–138] have systematically become denser 
by decreasing the size and increasing the number of electrode sites [32]. Even though performance 
variability occurs among different site locations [46,139], when compared to regular single-site 
microelectrodes [135], high-density microelectrodes allow independent placing of electrode sites within 
a single shaft, improving focal selectivity within cortical layers [140].  Task-specific design of 
microelectrodes can greatly benefit the selectivity and functionality necessary for particular 
neuroprosthetic applications. Advances in design and microfabrication, such as electron-beam 
lithography [141] and active CMOS electronic units [142] would allow for an increased number of traces 
and independent stimulation channels [143]. This next generation of microelectromechanical systems 
(MEMS) would greatly propel forward both microstimulation and recording capabilities [143]. In 
addition to conventional MEMS, the mechanical, electrical, and particularly, dimensional properties of 
carbon fibers have proven to be an attractive alternative to the manufacture of chronic electrical 
microelectrodes [144–146](Figure 3B). Even though these penetrating electrodes have been mostly 
developed as recording devices (essential for bidirectional BMI) [133], discrete modifications can be 
done to achieve electrostimulation [147,148].  Additionally, advances in material composition, 
compatibility, and deposition techniques have allowed a variety of microelectrode designs with different 
substrate profiles [36]. These advances have led to novel electrode designs that can potentially mediate 
the scale of the FBR, such as: mechanically dynamic probes [45], ultraflexible nanoelectronic threads 
[149], injectable mesh electrodes [150,151], as well as, endovascular stent electrodes [152]. Further 
studies are necessary to assess the chronic performance of these novel interfaces, as well as, their 
potential ability to neuromodulate surrounding neurons. Despite their obvious functional and 
theoretical advantages, penetrating microelectrodes face several practical challenges, primarily, 
biocompatibility-related. Device implantation inherently causes trauma, including blood-brain-barrier 
disruption [15], and neuronal death [38]. This initiates a FBR [37] by the immune system that triggers 
microglia [154,155] and astrocyte activation [156] leading to the formation of an indwelling glial sheath 
that surrounds the electrode [38–40] (Figure 2). Even though, this encapsulating glial sheath, as well as 
neuronal death, has been primarily associated with chronic decline in recordings [157,158] and not in 
stimulation [77], there is literature  suggesting that the FBR might have a role in, hindering chronic 
performance of focal micro-neuromodulation [140] (Figure 3A).  
Several multidisciplinary efforts are currently developing strategies to mitigate these effects 
[44], including electrical [47,48,159], mechanical [45,49–51], and chemical approaches [52,55–59] that 
may result in more biomimetic interfaces. A less invasive electrical microstimulation alternative is the 
use of intracranial electrode grid placed over the cortical surface denominated electrocorticography 
(ECoG) arrays. Microstimulation in humans with these devices have shown success [78] (see 
Somatosensory Neuroprostheses section). Likewise, novel reduced-size μECoG arrays [160,161] have 
shown great potential. However, the spatial resolution and effective neuromodulation of these are 
limited to the cortex, excluding critical deeper neuromodulation targets.  
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Figure 2.  
Overview of foreign body response to intracortical microelectrodes.  
Pre-implant phase (left) showing undisrupted tissue. Post-implant acute phase (center), characterized by 
mechanical brain blood barrier disruption and local bleeding (depicted in red), neuronal death, and activation of 
microglia. Chronic phase (right), characterized by additional neuronal death and astrocytic glial sheath surrounding 
the electrode, potentially impairing its performance. 
 
 Magnetic 
A conventional alternative to standard electrical stimulation is the use of induced electric fields 
from magnetic stimulation to modulate neural activity; such is the case of TMS. Through large hand-held 
coils that induce strong magnetic fields, TMS is able to modulate brain activity through the scalp [162]. 
TMS is commonly used for the treatment of neurological disorders, including, depression [15] and stroke 
[120]. Analogously, implantable-sized microcoils are capable of reaching neuronal activation thresholds 
through micromagnetic stimulation (µMS) [163]. This novel µMS technology offers several advantages 
over conventional electrical stimulation, including, potential MRI compatibility [163] and, high spatial 
resolution (<60 μm) [164]. Additionally, the focused spatial selectivity due to the asymmetric nature of 
elicited magnetic fields can selectively activate [164,165], or suppress [166] neurons depending on the 
coil orientation (Figure 3C). Moreover, neuronal modulation through the FBR may improve chronic 
performance of µMS relative to micro-electrical stimulation. Compared to conventional 
microelectrodes, these microcoils require a much higher power input to modulate neuronal activity 
[164,166]. Novel microcoil designs and materials can potentially reduce this power, as well as, 
dramatically increase their selectivity. Furthermore, additional longitudinal in vivo studies will help to 
validate the potential of µMS as a viable and safe micro-neuromodulation mechanism. 
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 Optical 
Optical neuromodulation, through cell-type specific genetically-inserted light-sensitive proteins 
(opsins) [167], opened the door for a different microstimulation paradigm, known as optogenetic 
neuromodulation [168]. In the past decade, optogenetics has been established as a powerful tool for 
neuroscience research [168,169]. Advances in optogenetic systems [170], as well as the ability to 
selectively activate or inhibit specific cell types [167](Figure 3D), has increased interest in optogenetic 
neuromodulation technologies [171]. Yet, this nascent technology faces many challenges for 
neuroprosthetic implementation, including low temporal resolution, complex interfaces, and more 
importantly, the necessity to genetically manipulate cells [167,168,172,173]. In this manner, 
multidisciplinary efforts to overcome some of these challenges have shown recent success. These 
include, subverting the need for genetic manipulation through gold nanoparticles [174], as well as the 
development wireless [175,176], fully implanted systems [176,177], and improved flexible 
multifunctional probes [178]. Similarly, implantable μECoG arrays for optogenetic recording and 
microstimulation have shown recent success [179]. Faster and more sensitive opsins will continue to 
increase the temporal resolution of this technique [143]. Analogously, the spatial resolution could be 
drastically improved by reductions in probe size and highly selective genetic labeling. Furthermore, 
advances in high-resolution genetic tagging efforts analogous to nucleotide barcoding [180] and 
Brainbow labeling [181], might one day allow micro-neuromodulation at cellular and sub-cellular 
resolution. 
 
Chemical and Thermal 
Alternatively, chemical and thermal neuromodulation technologies have also been proposed. 
Optically-induced thermal neuromodulation technologies, such as infrared neural stimulation (INS) [182] 
do not require genetic manipulation [139]. In vivo studies have shown that INS is able to effectively 
modulate neuronal activity of visual cortex [183] and peripheral nerves [182] with high selectivity [184]. 
Nevertheless, absence of thermally induced damage, spatiotemporal resolution, and chronic stability are 
yet to be proven in longitudinal studies [139]. On the other hand, selective injection of 
neurotransmitters [185], charged ions [186], or temperature-sensitive magnetic nanoparticles (MNP) 
[187,188] are capable of modulating neuronal activity with high precision [19]. Recently, a method of 
stimulation called magneto-thermal genetic stimulation was tested for the first time in freely behaving 
rats. Combining MNPs with non-invasive alternating magnetic fields, this stimulation method allows for 
high specificity of genetically-modified cells [189]. However, these technologies require further 
improvements in stimulation onsets. Currently, poor temporal resolution renders these 
neuromodulation technologies unfeasible for real-time neuroprostheses.  
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Figure 3. 
Representative biostability and chronic performance of current intracortical neuromodulation technologies.. 
Electrical microstimulation by (A) silicon and (B) carbon fiber microelectrodes showing different foreign body 
responses and relative performance (stimulated neurons). (C) Implantable-sized microcoil eliciting orientation-
based selective activation of neurons by micromagnetic stimulation (µMS) capable of passing though the glial scar. 
(D) Optical fiber probe eliciting cell type-specific optical stimulation after genetic modification (not shown). 
Non-invasive Neuromodulation 
Non-invasive neuromodulation technologies such as TMS [120] and transcranial current 
stimulation [122] have been available in the clinic for more than a decade. Even though these methods 
have the advantage of not requiring invasive procedures, these transcutaneous neuromodulation 
techniques have poor temporal and spatial resolution. Further, the unwieldy equipment necessary in 
the case of TMS renders these impractical for chronic neuroprostheses. Nevertheless, recent non-
invasive neuromodulation alternatives have emerged with improved spatial resolution. For example, 
transcranial focused ultrasound (tFUS) has demonstrated neuromodulation recently in human studies 
that has successfully elicited discrete somatosensory [190,191] and visual [192] percepts. Likewise, 
temporal interference (TI) electrical stimulation has recently demonstrated that transcranial electric 
field interference stimulation is capable of neuromodulation at a selective depth [193]. Further studies 
will look to demonstrate the practicality and spatiotemporal resolution of these technologies for their 
application in micro-neuromodulation.  
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Conclusion 
In conclusion, modern developments from the fields of medicine, neuroscience, and neural 
engineering are bringing the possibility of micro-neuromodulation closer for prosthetic and science 
applications. Recent studies in both human and animals have demonstrated the power of high-density, 
high-resolution neural interfaces to provide sensory, motor, and cognitive effects. Simultaneously, 
technologies from electronics, optics, and magnetics are continually being miniaturized to provide high-
density, robust interfaces that avoid some biotic failures associated with the FBR. As non-invasive 
stimulation techniques gradually improve, Short-term solutions to the spatial resolution obstacle will 
most likely be overcome through invasive penetrating electrodes. Like DBS and cochlear implants, the 
drawback associated with the implantation of these devices will be outweighed by their clinical success. 
Furthermore, technological advances in computational power, artificial intelligence, and 
microelectronics must be developed in parallel as stimulation neuroprostheses become more reliable 
and precise. As the BMI spotlight shifts from academic and biomedical grounds towards commercial 
endeavors within the next decade, we will see an inevitable shift from assistive technologies and 
therapeutics towards sensory augmentation, performance enhancement, and faster-than-thinking 
communications. Emerging companies such as Neuralink and Kernel are leading pioneering efforts 
towards these goals. As the incentives for innovation and development of neuroprosthetic interfaces 
increase, strides towards super-high resolution integrative BMI will continue to flourish. Truly, the ability 
to selectively micro-neuromodulate every single neuron in the brain will one day become a pillar of 
neuroscientific research, adding a functional layer of complexity to current multidisciplinary brain 
mapping initiatives. 
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